Search

Your search keyword '"Ito, Tomoki"' showing total 825 results

Search Constraints

Start Over You searched for: Author "Ito, Tomoki" Remove constraint Author: "Ito, Tomoki"
825 results on '"Ito, Tomoki"'

Search Results

1. Clinical characteristics in adolescents and young adults with polycythemia vera and essential thrombocythemia in Japan

2. The impact of renal function on initial therapy in transplant-ineligible multiple myeloma patients

3. Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: a multicenter retrospective study

5. Predictive significance of high neutrophil ratio for thrombosis in myeloproliferative neoplasms: JSH-MPN-R18 subanalysis

6. Prevalence of chromosome 8p11.2 translocations and correlation with myeloid and lymphoid neoplasms associated with FGFR1 abnormalities in a consecutive cohort from nine institutions in Japan

8. Correction to: Predictive significance of high neutrophil ratio for thrombosis in myeloproliferative neoplasms: JSH-MPN-R18 subanalysis

9. The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients

10. Prevalence and causes of subacute cough in Japan

11. Real-world data on induction therapy in patients with transplant-ineligible newly diagnosed multiple myeloma: retrospective analysis of 598 cases from Kansai Myeloma Forum

12. Prevalence and causes of chronic cough in Japan

16. Efficacy of elotuzumab for multiple myeloma in reference to lymphocyte counts and kappa/lambda ratio or B2 microglobulin

18. Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial

19. Deep Recurrent Factor Model: Interpretable Non-Linear and Time-Varying Multi-Factor Model

20. Clinical characteristics of Japanese patients with polycythemia vera: results of the JSH-MPN-R18 study

22. Real-world treatment patterns and clinical outcomes in patients with AML in Japan who were ineligible for first-line intensive chemotherapy

23. Clinical characteristics, prognostic factors, and outcomes of patients with essential thrombocythemia in Japan: the JSH-MPN-R18 study

26. Segment Information Extraction from Financial Annual Reports Using Neural Network

27. Concept Cloud-Based Sentiment Visualization for Financial Reviews

32. Comparison of starting doses of anagrelide as a first-line therapy in patients with cytoreductive therapy-naïve essential thrombocythemia: difference between starting at 0.5 and 1.0 mg/day

36. An observational study of once-weekly carfilzomib in patients with multiple myeloma in Japan (Weekly-CAR study)

37. Long‐term treatment with fostamatinib in Japanese patients with primary immune thrombocytopenia: An open‐label extension study following a phase 3 placebo‐controlled, double‐blind, parallel‐group study

41. Text-Visualizing Neural Network Model: Understanding Online Financial Textual Data

44. Extraction of Bi-graph Structures Among Multilingual Financial Words Using Text-Mining Methods

47. Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial

Catalog

Books, media, physical & digital resources